Pharmaceutical Legislative Update
by William C. Waller

Modest Reforms Could Yield Major Advances in Device Regulation
by James S. Benson

Medical Technology: Healing the Patient—and the Healthcare System
by Megan M. Ivory

A New Beginning
by Jerome A. Halperin

FDLI Honors Villforth
by M. Cathryn Butler

Unguided Missives: The FDA and Prescription Drug Promotion in Cyberspace
by James D. Arden

Pharmaceutical Industry Next Target For Developing, Implementing Comprehensive Compliance Programs
by Debbie McAllister and Nicole DeVuono

Student Training Sustains Institute Tradition
by M. Cathryn Butler

Book Review—Body Bazaar:
The Market for Human Tissue in the Biotechnology Age
by Richard H. Parrish II

Squaring Off on Over-the-Counter Status: WellPoint Versus the Antihistamine Manufacturers
by Susan L. Burke and Valerie E. Hurt

Detention Without Physical Examination
by Marvin A. Blumberg

Making History
Folic Acid Fortification: Fact and Folly, Part II
by Suzanne White Junod

Enforcement Corner
The Shape of Things to Come: U.S. v. LifeScan
by Steven M. Kowal

Global Corner
The European Commission's Review of Pharmaceutical Legislation
by Sophie G. Anderson, Ph.D.

Associates' Corner
Premarket Consultation of Bioengineered Food and Animal Feed
by Kathleen F. Howlett